Twenty years of EMBLEM

Reflecting on 20 years of EMBLEM…

By Cella Carr

Lab Matters

EMBL spinoff Velabs Therapeutics to help antibody discovery. IMAGE: Velabs Therapeutics

EMBL spinoff to help antibody discovery

New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies…

By Iris Kruijen

Lab Matters

EMBL spin-off Luxendo acquired by Bruker

Accelerating researchers’ access to next-generation light-sheet microscopy…

By Sonia Furtado Neves

Lab Matters

New EMBL and GSK collaboration

GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms…

By Sonia Furtado Neves

Lab Matters

Digital zebrafish embryo provided the first complete developmental blueprint of a vertebrate in 2008. IMAGE: EMBL/Keller et al.

SPIM doctors

From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.…

By Sam Lemonick


Lighting the way

A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…

By Guest author(s)

Lab Matters

The transparent organism

A novel high-tech microscope will be brought to the marketplace, giving laboratories everywhere fascinating new insights into living organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial entity of the European Molecular Biology Laboratory (EMBL), announced today that it has signed a…

By Guest author(s)

Lab Matters


Read the latest Issues of our magazine - EMBLetc.

Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.

EMBLetc. archive